Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06126835 · ClinicalTrials.gov registry record
A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants
A clinical trial of Ulcerative Colitis, sponsored by Bristol-Myers Squibb.
- Active
- Registry status
- 2,828
- Enrollment target
- 1
- Study location
NCT06126835 is a study of Ulcerative Colitis that is active but no longer recruiting, run by Bristol-Myers Squibb. The registered enrollment target is 2,828 participants, above the 2,034-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (39% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06126835, a study of Ulcerative Colitis, is active but no longer recruiting, sponsored by Bristol-Myers Squibb.
- ACTIVE NOT RECRUITING
- Registry status
- 2,828 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this retrospective observational cohort study is to assess pregnancy and infant outcomes in three groups: the first is women with ulcerative colitis (UC) who were exposed to ozanimod during pregnancy; the second is women with UC exposed to conventional therapy during pregnancy; the third is women with UC exposed to advanced therapy during pregnancy. This study will use data from a large US healthcare claims database.
Conditions Studied
Interventions
- DRUG Ozanimod
- DRUG Conventional therapy
- DRUG Advanced therapy
Study Locations (1)
Minnesota
- OptumInsight Life Sciences Inc - Eden Prairie
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,828 participants |
| Start Date | 2024-08-26 |
| Est. Completion | 2032-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06126835
The ClinicalTrials.gov registry entry for NCT06126835 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,828 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,034-participant average among 122 other Ulcerative Colitis trials with a reported enrollment target (39% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ulcerative Colitis appearing as the primary indexed condition, and to 3 interventions - of which Ozanimod is the first listed.
NCT06126835 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT06126835 about?
NCT06126835 is a clinical study titled "A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants". The purpose of this retrospective observational cohort study is to assess pregnancy and infant outcomes in three groups: the first is women with ulcerative colitis (UC) who were exposed to ozanimod during pregnancy; the second is women with UC exposed to conventional therapy during pregnancy; the th...
What is the current status of trial NCT06126835?
This trial is currently active not recruiting. The enrollment target is 2,828 participants. The study started on 2024-08-26. Estimated completion is 2032-06-30.
What conditions does trial NCT06126835 study?
This clinical trial studies the following conditions: Ulcerative Colitis.
What interventions are being tested in trial NCT06126835?
The interventions under investigation include: Ozanimod (DRUG), Conventional therapy (DRUG), Advanced therapy (DRUG).
Who is sponsoring clinical trial NCT06126835?
This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06126835 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ulcerative Colitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RECRUITING · Phase 2
-
Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
RECRUITING
-
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
RECRUITING · NA
-
A Study of Endoscopic Sleeve Gastroplasty for Obesity in Ulcerative Colitis
RECRUITING · NA
-
Registry and Biorepository for IBD in Central Texas
RECRUITING
-
Nicotinamide Riboside in Ulcerative Colitis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.